中国及全球TAVI概述

Overview of TAVI in China and around the globe

11/03 10:20-11:00

主会场

10:20-11:00

主持:

Chairpersons:

Christoph NABER, Ashok SETH
10:20-11:00

讨论专家:

Panelists:

陈茂, Kentaro HAYASHIDA, Yat-Yin LAM, Scott LIM, Lars SØNDERGAARD, 殷伟贤
10:20-11:00

学习目标:>了解中国TAVI的现状、挑战及未来展望>全面认识全球TAVI的现状及未来>学习如何为主动脉瓣疾病患者选择最佳治疗时机及最佳治疗方式

Attend this session if you want:>To know the current status, problems and future of TAVI in China>To get a comprehensive update about the current and future scope of TAVI worldwide>To learn how to select the best timing and mode of intervention for patients with aortic valve disease
10:20-10:22

学习目标介绍

Session objectives

Christoph NABER
10:22-10:30

中国TAVI的现状、挑战及未来展望

TAVI in China: current status, problems and future perspectives

高润霖
10:30-10:34

讨论 React @ PCCV

Discussion React @ PCCV
10:34-10:42

当前和未来的TAVI适应症

Current and future TAVI indications

Christoph NABER
10:42-10:46

讨论 React @ PCCV

Discussion React @ PCCV
10:46-10:54

2017 ESC/EACTS瓣膜病管理指南解读: 主动脉瓣疾病患者的管理

2017 ESC/EACTS Guidelines: key messages about the management of aortic valve disease

Bernard PRENDERGAST
10:54-10:58

讨论 React @ PCCV

Discussion React @ PCCV
10:58-11:00

总结

Session evaluation and key learnings

Ashok SETH
11:00-11:20

茶歇

Coffee and tea break

打印